ABP
Abpro Holdings, Inc.
Key Financials
Revenue
$183000
↑ 50.0%
Net Income
$2.8M
↑ 218.1%
Operating Income
$-8452000
↑ 14.8%
EPS (Diluted)
$-1.30
↓ 75.7%
Total Assets
$1.1M
↓ 77.2%
Shareholders' Equity
$-8831000.00
↑ 43.0%
Total Liabilities
$19.6M
↑ 5.5%
Cash & Equivalents
$2.9M
↑ 977.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 4/15/2026 | View on SEC |
| NT 10-K | 3/31/2026 | View on SEC |
| 8-K | 2/20/2026 | View on SEC |
| 8-K | 2/11/2026 | View on SEC |
| SCHEDULE 13G | 2/9/2026 | View on SEC |
| 8-K | 2/3/2026 | View on SEC |
| 8-K | 1/23/2026 | View on SEC |
| 8-K | 1/6/2026 | View on SEC |
| 8-K | 12/15/2025 | View on SEC |
| 8-K | 12/9/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABP |
| Company Name | Abpro Holdings, Inc. |
| CIK | 1893219 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | OTC |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 248-890-7200 |